These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 12545338

  • 1. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
    Richter MH, Richter HR, Olbrich HG, Mohr FW.
    Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
    [Abstract] [Full Text] [Related]

  • 2. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
    Richter M, Skupin M, Grabs R, Schramm D, Richter H, Olbrich HG.
    J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
    [Abstract] [Full Text] [Related]

  • 3. Do vascular compartments differ in the development of chronic rejection? AT(1) blocker candesartan versus Ace blocker enalapril in an experimental heart transplant model.
    Richter M, Richter H, Skupin M, Mohr FW, Olbrich HG.
    J Heart Lung Transplant; 2001 Oct; 20(10):1092-8. PubMed ID: 11595564
    [Abstract] [Full Text] [Related]

  • 4. alpha4beta1-integrin blockade and cyclosporine decreases the prevalence and severity of transplant vasculopathy in a rat transplant model.
    Richter MH, Wehner V, Kock M, Falk V, Richter H, Stilz HU, Lippek F, Schollmann HJ, Gummert JF, Mohr FW.
    J Heart Lung Transplant; 2004 Nov; 23(11):1266-76. PubMed ID: 15539125
    [Abstract] [Full Text] [Related]

  • 5. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
    Azzadin A, Małyszko J, Małyszko JS, Tankiewicz A, Myśliwiec M, Buczko W.
    Pol J Pharmacol; 2002 Nov; 54(5):469-73. PubMed ID: 12593533
    [Abstract] [Full Text] [Related]

  • 6. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
    Smit-van Oosten A, Navis G, Stegeman CA, Joles JA, Klok PA, Kuipers F, Tiebosch AT, van Goor H.
    J Pathol; 2001 May; 194(1):122-9. PubMed ID: 11329151
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
    Bouchard D, Despatis MA, Buluran J, Cartier R.
    Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
    [Abstract] [Full Text] [Related]

  • 9. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
    Rashtchizadeh N, Aghaeishahsavari M, Argani H, Noroozianavval M, Veisi P, Ghorbanihaghjo A.
    Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
    [Abstract] [Full Text] [Related]

  • 10. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 11. [In contrast to captopril and enalapril, losartan does not increase mortality of gerbils after carotid ligation].
    Mazouz H, Oprisiu R, Monge M, Andrejak M, Fournier A.
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):813-7. PubMed ID: 11575209
    [Abstract] [Full Text] [Related]

  • 12. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model.
    Kobayashi J, Crawford SE, Backer CL, Zales VR, Takami H, Hsueh C, Huang L, Mavroudis C.
    Circulation; 1993 Nov; 88(5 Pt 2):II286-90. PubMed ID: 8222167
    [Abstract] [Full Text] [Related]

  • 13. Interaction between AT1 and alpha1-adrenergic receptors in cardiomyopathic hamsters.
    Crespo MJ.
    J Card Fail; 2000 Sep; 6(3):257-63. PubMed ID: 10997753
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H.
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study.
    Richter MH, Richter H, Barten M, Schramm D, Gummert J, Mohr FW, Skupin M, Olbrich HG.
    Transplant Proc; 2002 Aug; 34(5):1484-5. PubMed ID: 12176450
    [No Abstract] [Full Text] [Related]

  • 16. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
    Moien-Afshari F, Choy JC, McManus BM, Laher I.
    J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
    Gündüz F, Kuru O, Sentürk UK.
    Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614
    [Abstract] [Full Text] [Related]

  • 18. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice.
    Sasaki M, Uehara S, Ohta H, Taguchi K, Kemi M, Nishikibe M, Matsumoto H.
    Life Sci; 2004 Jul 02; 75(7):869-80. PubMed ID: 15183078
    [Abstract] [Full Text] [Related]

  • 19. Effects of losartan and enalapril on high-sensitivity C-reactive protein and total antioxidant in renal transplant recipients with Renin-Angiotensin system polymorphisms.
    Argani H, Ghorbanihaghjo A, Aghaeishahsavari M, Noroozianavval M, Rashtchizadeh N, Veisi P, Safa J, Abediazar S.
    Transplant Proc; 2008 Jul 02; 40(1):16-21. PubMed ID: 18261537
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
    Zhu BQ, Sievers RE, Browne AE, Lee RJ, Chatterjee K, Grossman W, Karliner JS, Parmley WW.
    J Renin Angiotensin Aldosterone Syst; 2003 Mar 02; 4(1):31-7. PubMed ID: 12692751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.